Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $268M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 4,632,149 | $128M | 47.6% | $16.43 | +60.2% | COM | 60770K107 |
| SANA | Sana Biotechnology Inc | 25,001,856 | $68.26M | 25.4% | $32.56 | -93.7% | COM | 799566104 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $59.57M | 22.2% | $19.16 | -78.2% | COM | 344174107 |
| MCRB | Seres Therapeutics Inc | 1,155,850 | $12.84M | 4.8% | $8.80 | 0.0% | COM | 81750R201 |